Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system
(CNS) in which inflammation, demyelination, and axonal loss occurs from the very early …

Multiple sclerosis (MS) is a complex neurodegenerative disease affecting the central
nervous system (CNS). The onset of MS has been typically observed in individuals aged …

Multiple sclerosis (MS) is the commonest non‐traumatic disabling disease to affect young
adults. The incidence of MS is increasing worldwide, together with the socioeconomic …

Multiple sclerosis (MS), the most common disabling neurologic disease of young people,
afflicts approximately a quarter of a million Americans. The symptoms of MS result from …

Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the
central nervous system (CNS). 1, 2 MS attacks the myelinated axons in the CNS, destroying …

Multiple sclerosis (MS) is the most common disabling neurologic condition in young adults
and imposes high financial and quality of life costs on patients, their families, and society …

Multiple sclerosis (MS) is a chronic but incurable disease of the central nervous system
(CNS) that is often diagnosed in the second or third decade of life. It is more common among …

The variability in the severity and clinical course of multiple sclerosis (MS) has as its basis
an extreme heterogeneity in the location, nature and extent of pathology in the brain and …

We have entered a golden era in multiple sclerosis (MS) research. Two decades ago, our
understanding of the disease was largely descriptive and there were no approved therapies …

Multiple sclerosis (MS) has been thought to be a complex and indecipherable disease, and
poorly understood with regards to aetiology. Here, we suggest an emphatically positive view …